Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Markell, M. S.
Right arrow Articles by Sumrani, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Markell, M. S.
Right arrow Articles by Sumrani, N.

Journal of the American Society of Nephrology, Vol 4, S37-S47, Copyright © 1994 by American Society of Nephrology

REVIEWS

Hyperlipidemia and glucose intolerance in the post-renal transplant patient

MS Markell, V Armenti, G Danovitch and N Sumrani
Division of Nephrology, SUNY Health Science Center at Brooklyn 11203.

This review examines the relationship between renal transplantation and two important metabolic consequences: hyperlipidemia and glucose intolerance. Before cyclosporine, hypertriglyceridemia and hypercholesterolemia were common abnormalities that worsened in the cyclosporine era. In addition to obesity, steroid use, and reduced renal function, cyclosporine plays an independent role in elevating cholesterol levels, with particular reference to the modulation of the low-density lipoprotein receptor. Management includes maintaining low levels of steroid, manipulation of cyclosporine appropriately, diets low in fat and cholesterol, and an exercise program. Pharmacologic management in general revolves around the HMG-COA reductase drugs, which can be used safely if liver function tests and muscle enzymes are monitored. The unmasking of clinically important glucose intolerance occurs in 5 to 10% of patients in the cyclosporine era, not different from the earlier experience. Steroids and cyclosporine independently can worsen glucose tolerance to unmask a genetic predisposition to Type II diabetes in some and to even create glucose intolerance in otherwise normal individuals. Management is based on dietary and immunosuppressive drug dosing manipulations and the judicious use of oral hypoglycemic agents. Half of these recipients may ultimately need insulin. In summary, hyperlipidemia and glucose intolerance remain important metabolic consequences of renal transplantation that affect long-term patient survival unless recognized and treated.


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
P. J Taylor, P. A Kubler, S. V Lynch, J. Allen, M. Butler, and P. I Pillans
Effect of Atorvastatin on Cyclosporine Pharmacokinetics in Liver Transplant Recipients
Ann. Pharmacother., February 1, 2004; 38(2): 205 - 208.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. Hjelmesath, A. Hartmann, K. Midtvedt, S. Aakhus, J. Stenstrom, L. Morkrid, T. Egeland, H. Tordarson, and P. Fauchald
Metabolic cardiovascular syndrome after renal transplantation
Nephrol. Dial. Transplant., May 1, 2001; 16(5): 1047 - 1052.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
E. de Pascale, M. Giordano, M. Carone, C. Pluvio, M. Pluvio, T. Criscuolo, L. Infantone, and P. Castellino
Impaired glucose oxidation and glucose-induced thermogenesis in renal transplant recipients
Nephrol. Dial. Transplant., October 1, 2000; 15(10): 1658 - 1662.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. Wu, Y. H. Zhu, and S. B. Patel
Cyclosporin-induced dyslipoproteinemia is associated with selective activation of SREBP-2
Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1087 - E1094.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673